¹⁸F-FAMT in patients with multiple myeloma: clinical utility compared to ¹⁸F-FDG.
Isoda A, Higuchi T, Nakano S, Arisaka Y, Kaira K, Kamio T, Mawatari M, Matsumoto M, Sawamura M, Tsushima Y.
Isoda A, et al. Among authors: tsushima y.
Ann Nucl Med. 2012 Dec;26(10):811-6. doi: 10.1007/s12149-012-0645-9. Epub 2012 Aug 18.
Ann Nucl Med. 2012.
PMID: 22903817
Clinical Trial.